AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clin Infect Dis. 15 oct 2017;65(8):1316‑26. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28531260
Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. lancet HIV. 1 août 2017;4(8):e349‑56. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28501495
Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, et al. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. HIV Med. 1 janv 2017;18(1):33‑44. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/27625009
Caby F, writing committee of the CD4+/CD8+ Ratio Working Group of the French Hospital Database on HIV (FHDH-ANRS CO4). CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals. AIDS. 31 juill 2017;31(12):1685‑95. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28700392
Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, et al. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. lancet HIV. 1 juin 2017;4(6):e251‑9. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28411091
Chêne G, Phillips A, Costagliola D, Sterne JAC, Furrer H, Del Amo J, et al. Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Int J Epidemiol. 1 juin 2017;46(3):797-797n. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/27864413
Chereau F, Madec Y, Sabin C, Obel N, Ruiz-Mateos E, Chrysos G, et al. Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers. PLoS One. 1 avr 2017;12(4):e0173893. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28380038
Gourlay A, Noori T, Pharris A, Axelsson M, Costagliola D, Cowan S, et al. The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges. Clin Infect Dis. 15 juin 2017;64(12):1644‑56. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28369283
Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D. Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV – ANRS CO4. PLoS One. 1 oct 2017;12(10):e0184441. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28968404
Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, et al. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Med. 1 mars 2017;18(3):171‑80. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/27625109
Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, et al. Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older. J Acquir Immune Defic Syndr. 1 nov 2017;76(3):311‑8. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28746165
Lusivika-Nzinga C, Selinger-Leneman H, Grabar S, Costagliola D, Carrat F. Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination. BMC Med Res Methodol. 4 déc 2017;17(1):160. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/29202691
Mangal TD, UNAIDS Working Group on CD4 Progression and Mortality Amongst HIV Seroconverters including the CASCADE Collaboration in EuroCoord. Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection. AIDS. 15 mai 2017;31(8):1073‑82. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28301424
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe. AIDS. 27 mars 2017;31(6):835‑46. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28272136
Trickey A, May MT, Schommers P, Tate J, Ingle SM, Guest JL, et al. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC). Clin Infect Dis. 15 sept 2017;65(6):959‑66. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/28903507
Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, et al. CD4 cell count response to first-line combination ART in HIV2+ patients compared with HIV1+ patients: a multinational, multicohort European study. J Antimicrob Chemother. 1 oct 2017;72(10):2869‑78. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/29091198
